Neurology Alert (Vol. 36, No. 7) - March 1, 2017

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: March 2017

Valid through: March 2020

Target Audience

This activity is intended for the neurologist.

Subjects

  • New Tools for the Diagnosis of CJD
  • Ocrelizumab for Multiple Sclerosis
  • Differences in Disease Duration in LBD May Be Related to Pathologic Burden
  • Guillain-Barré Syndrome and Hepatitis E
  • EEG Reactivity Testing in Comatose Patients After Severe Brain Injury
  • First-ever Study of Genome Sequencing in the Common Forms of Epilepsy

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Joseph E. Safdieh, MD, Vice Chair and Associate Professor, Weill Cornell Medical College

Jai S. Perumal, MD, Assistant Professor of Neurology, Weill Cornell Medical College

Harini Sarva, MD, Assistant Professor of Clinical Neurology, Weill Cornell Medical College; Assistant Attending Neurologist, NewYork Presbyterian Hospital

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Peter B. Forgacs, MD, Assistant Professor of Neuroscience and Neurology, Feil Family Brain & Mind Research Institute and Department of Neurology, Weill Cornell Medical College; Adjunct Assistant Professor of Clinical Investigation, The Rockefeller University

M. Elizabeth Ross, MD, PhD, Nathan E. Cumming Professor of Neurology and Neuroscience, Chair, Neuroscience Graduate Program, Weill Cornell Medical College

Editors

Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media Executive Editor: Leslie G. Coplin

Editor: Jonathan Springston

Financial Disclosure

Author Jai S. Perumal, MD, reports she receives grant/research support from Genzyme Corp., and is on the speakers bureau for Biogen Idec, Genzyme Corp., Acorda Therapeutics, and Teva Pharmaceuticals. Matthew E. Fink, MD reports he is a consultant for Procter & Gamble.

Authors Joseph E. Safdieh, MD; Harini Sarva, MD; Michael Rubin, MD; Peter B. Forgacs, MD; and M. Elizabeth Ross, MD, PhD, report no financial relationships relevant to this field of study.

Neurology Alert's editor in chief, Matthew E. Fink, MD reports he is a consultant for Procter & Gamble. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Copyright 2017, AHC Media. All rights reserved.